|
A BI-WEEKLY PUBLICATION FROM THE CEDARS-SINAI CHIEF OF STAFF
Aug. 20, 2010 Issue
| Archived Issues
Physician NewsFDA Proposes Withdrawal of MidodrinePharmacy Focus The U.S. Food and Drug Administration proposed to withdraw marketing approval of midodrine, a drug used to treat low blood pressure. The administration also issued a "notice of opportunity for a hearing" to the companies that manufacture midodrine. Meetings and EventsHigh Holiday Services – Sept. 9, 17, 18 Rehabilitation Topics on the Neurological and Neurovascular Treatment of Stroke – Sept. 11 Politics and PBS: What You Don't See on TV – Sept. 24 Heart Institute Opens California's First Advanced Heart Failure Inpatient Unit
Drug reduces tumor size in ovarian, breast cancer patientsResearch CornerAn international consortium of researchers that included William Audeh, M.D., of Cedars-Sinai has shown that an investigational drug can reduce the size of tumors in women with advanced hereditary ovarian cancer with BRCA gene mutations. » Read moreViewing CME Credits in Web/VSWeb/VS Tip of the Week You can view your CME credits in Web/VS by following these steps ... » Read moreImaging Case of the Month for August
|
The Cedars-Sinai Heart Institute has opened an innovative 30-bed inpatient unit dedicated to providing advanced heart failure patients with an intensive, multidisciplinary approach to inpatient care. The unit on 6 South East formally opened late last month.
Make your diagnosis